Clinical trials
Phase 2 trials in Georgia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
227 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 9 |
| 2015 | 9 |
| 2016 | 12 |
| 2017 | 10 |
| 2018 | 13 |
| 2019 | 8 |
| 2020 | 19 |
| 2021 | 30 |
| 2022 | 14 |
| 2023 | 25 |
| 2024 | 17 |
| 2025 | 21 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 122 |
| Active, not recruiting | 39 |
| Terminated | 36 |
| Recruiting | 18 |
| Unknown status | 6 |
| Enrolling by invitation | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Pfizer | 7 |
| Gilead Sciences | 6 |
| Sanofi | 6 |
| Immunovant Sciences GmbH | 5 |
| Regeneron Pharmaceuticals | 5 |
| Lakefront Biotherapeutics NV | 4 |
| Relypsa, Inc. | 4 |
| Ablynx, a Sanofi company | 3 |
| Afimmune | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 27 |
| Arthritis, Rheumatoid | 20 |
| Inflammatory Bowel Diseases | 13 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Crohn Disease | 10 |
| Heart Failure | 8 |
| Lupus Erythematosus, Systemic | 7 |
| Renal Insufficiency, Chronic | 7 |
| Breast Neoplasms | 6 |
| Asthma | 5 |
Trials
Showing 26 to 50 of 227. Each trial links to its page on Pharma Observatory.
127 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.